Exercise With Individual Dosage Against the Best Current Practice in Lower Limb Tendinopathy (MaLaGa Trial)
Launched by UNIVERSITY OF MALAGA · Feb 21, 2019
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The MaLaGa Trial is a clinical study that looks at how different exercise programs can help people with lower limb tendinopathy, which is a condition that causes pain in tendons like the Achilles, patellar, or gluteal tendons. In this trial, researchers will compare a new exercise program that tailors the amount of exercise to each individual’s needs with the current best treatment available. About half of the participants will follow the new exercise plan, while the other half will receive the standard care.
To be eligible for this trial, participants should be adults aged 18 to 65 with a confirmed diagnosis of mid-portion Achilles, patellar, or gluteal tendinopathy that has caused pain for at least one month. However, individuals who have had certain treatments like corticosteroid injections in the past year or have other significant injuries or surgeries affecting the same leg will not be able to participate. Those who join the study can expect to engage in either the new exercise program or the best current treatment, contributing to important research that could improve care for others with similar conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. People between 18 and 65 years with a clinical diagnosis of mid-portion Achilles, patellar, or gluteal tendinopathy;
- • 2. Pain duration for at least one month.
- Exclusion Criteria:
- • 1. Corticosteroid injection in the studied tendon in the last 12 months;
- • 2. Other injuries in the affected lower limb in the last 12 months;
- • 3. Previous surgery for musculoskeletal causes of the affected lower limb in the last 12 months;
- • 4. Tendinous rupture history in the affected lower limb;
- • 5. Systemic diseases such as rheumatic arthritis or diabetes mellitus.
About University Of Malaga
The University of Malaga, a leading academic institution in Spain, is committed to advancing medical research and improving patient outcomes through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise in various fields, including medicine, health sciences, and biotechnology, to conduct rigorous studies. The institution is dedicated to fostering a culture of ethical research practices and ensuring the highest standards of safety and efficacy in its clinical trials, ultimately contributing to the development of groundbreaking therapies and enhancing the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials